Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): An interobserver study among genitourinary pathologists

American Journal of Surgical Pathology

Volumn 38, Issue 2, 2014, Pages 167-175

  Ananthanarayanan, Vijayalakshmi ^a   Pan, Yi ^b   Tretiakova, Maria ^a,r   Amin, Mahul B ^d   Cheng, Liang ^e   Epstein, Jonathan I ^f   Grignon, David J ^e   Hansel, Donna E ^g   Jimenez, Rafael E ^h   McKenney, Jesse K ⁱ   Montironi, Rodolfo ^o   Oliva, Esther ^j   Osunkoya, Adeboye O ^c   Rao, Priya ^k   Reuter, Victor E ^m   Ro, Jae Y ^l   Shen, Steven S ^l   Srigley, John R ^p   Tsuzuki, Toyonori ^q   Yao, Jorge L ⁿ   Antic, Tatjana ^a   Haber, Michael ^b   Taxy, Jerome B ^a   Paner, Gladell P ^a   more..

^a UNIVERSITY OF CHICAGO   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h MAYO CLINIC   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^l HOUSTON METHODIST HOSPITAL   (United States)

^m MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁿ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^o UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^p MCMASTER UNIVERSITY   (Canada)

^q NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^r UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

bladder; cancer; interobserver; pT3a; reproducibility; staging

Indexed keywords

ARTICLE; BIOPSY; BLADDER; BLADDER TUMOR; CANCER STAGING; CLASSIFICATION; COMPARATIVE STUDY; EPIDEMIOLOGY; HUMAN; NOMENCLATURE; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; TUMOR INVASION;

BIOPSY; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TERMINOLOGY AS TOPIC; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84893001880     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000096     Document Type: Article

References (28)

1. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21:690-696.
2. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 2006;176:2414-2422.
3. Costantini C, Millard F. Update on chemotherapy in the treatment of urothelial carcinoma. Scientific World Journal. 2011;11:1981-1994.
4. Meeks JJ, Bellmunt J, Bochner BH, et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2012;62:523-533.
5. Sternberg CN, Bellmunt J, Sonpavde G, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. Eur Urol. 2013;63:58-66.
6. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
7. Bastian PJ, Hutterer GC, Shariat SF, et al. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. BJU Int. 2008;101:450-454.
8. Hautmann RE, Gschwend JE, de Petriconi RC, et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol. 2006;176:486-492.
9. Quek ML, Stein JP, Clark PE, et al. Microscopic and gross extravesical extension in pathological staging of bladder cancer. J Urol. 2004;171:640-645.
10. Scosyrev E, Yao J, Messing E. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice. Urology. 2010;76:908-914.
11. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol. 2001;19:666-675.
12. Zarei S, Frank I, Boorjian SA, et al. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications. J Urol. 2012;188:1706-1711.
13. Clark PE, Agarwal N, Biagioli MC, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guideliness) Bladder Cancer Version 1.2013. November 19, 2012. Available at: http://www.nccn.org/professionals/physician- gls/pdf/bladder.pdf. Accessed March 26, 2013.
14. Bochner BH, Nichols PW, Skinner DG. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder. Urology. 1995;45:528-531.
15. Paner GP, Ro JY, Wojcik EM, et al. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2007;31: 1420-1429.
16. Philip AT, Amin MB, Tamboli P, et al. Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis. Am J Surg Pathol. 2000;24:1286-1290.
17. Amin MB, McKenney JK, Paner GP, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol. 2013;63:16-35.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
19. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
20. Svatek RS, Shariat SF, Lasky RE, et al. The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res. 2010;16:4461-4467.
21. Tilki D, Svatek RS, Karakiewicz PI, et al. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. J Urol. 2010;184:470-474.
22. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol. 2005;48:189-201.
23. Cognetti F, Ruggeri EM, Felici A, et al. Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. Ann Oncol. 2012;23:695-700.
24. Lehmann J, Franzaring L, Thuroff J, et al. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. BJU Int. 2006;97:42-47.
25. Lehmann J, Retz M, Wiemers C, et al. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol. 2005;23:4963-4974.
26. Pas-Ares LG, Solsona E, Esteban E, et al. Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01 study. J Clin Oncol. 2010;28:18s.
27. Sternberg CN, Theodore C, Nilsson S, et al. Comparison of immediate and delayed adjuvant chemotherapy in treating patients who have undergone a radical cystectomy for stage III or stage IV transitional cell carcinoma of the bladder urothelium. January 11, 2013. Available at: http://clinicaltrials.gov/ct2/show/ NCT00028756. Accessed March 26, 2013.
28. Boudreaux KJ Jr, Chang SS, Lowrance WT, et al. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Cancer. 2009;115:770-775.